Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Shivendra Kumar

Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend

Sun Pharmaceuticals on Friday reported a consolidated net profit of Rs 2,714 crore for the March-ended quarter, up 22% from Rs 2,150 crore in the year-ago period. The drugmaker also posted a 13% increase in revenue to Rs 14,612 crore in Q4FY26, compared with Rs 12,959 crore in the corresponding quarter of the previous financial year.

However, profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.